Skip to main content

06-05-2022 | ADA 2022 | Conference coverage | News

Vitamin B12 monitoring rare despite metformin prescription

Author: Eleanor McDermid


medwireNews: Clinicians are only rarely monitoring vitamin B12 levels in people with type 2 diabetes using metformin, research shows.

“Increased awareness of the relationship between metformin and Vitamin B12 deficiency and standardized approaches to monitoring are needed,” say researchers Ronak Ghiya and Maya Fayfman, both from Emory University School of Medicine in Atlanta, Georgia, USA.

The team presented the findings in the late-breaking poster session at the 82nd ADA Scientific Sessions in New Orleans, Louisiana.

Among 30,803 people prescribed metformin and recorded in the medical records of a single hospital outpatient center in Atlanta, just 2.6% had vitamin B12 measured. The rate of vitamin B12 measurement was 7.5% among people seen in primary care and even lower, at 2.3%, among those attending the endocrinology department.

The monitoring rate was only slightly higher among people with neuropathy, at 10.1% and 3.7% for those seen in primary care and endocrinology, respectively.

medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2022 Springer Healthcare Ltd, part of the Springer Nature Group

ADA Scientific Sessions; New Orleans, Louisiana: 3–7 June 2022


ADA 2022 coverage

Access the latest news and expert insight from the ADA 82nd Scientific Sessions

New additions to the Adis Journal Club

A selection of topical peer-reviewed articles from the Adis journals, curated by the editors.